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Abstract
Background: Cardiac catheterization is performed for both therapeutic and diagnostic reasons, in which the
outcome may vary from only medical treatment to the need of percutaneous coronary intervention and ending
with coronary artery bypass graft. The primary goal of this study was to determine predictors of revascularization.
Methods: A retrospective cohort study was conducted on data collected from records of patients who underwent
cardiac catheterization at Al-Arabi Heart Center in Palestine in 2017. Multivariate logistic regression analysis was carried
out to assess the association of sociodemographic and pre-catheterization clinical predictors with revascularization.
Results: A total of 1550 patients were included in the study. The participants mean age was 58 with a SD of 11.7 years,
73.6% were males. 50.2% of patients who underwent an interventional cardiac catheterization tested negative for
troponin on presentation. Multivariate logistic regression showed Troponin (RR = 4.5), Age (RR = 1.0), Female gender
(RR = 0.4) previous catheterization (RR = 2.0), and existence of diabetes as significant predictors for revascularization. The
correlation between ECG on presentation and the subsequent need for an interventional cardiac catheterization was
significant only in case of ST-Elevation (RR = 1.5), and T wave inversion (RR = 1.6). CK-MB, Hypertension and ECG with
ST-depression were not significant predictors.
Conclusion: This study assessed revascularization predictors in addition to characteristics and outcomes of patients
who have undergone cardiac catheterization. The results showed the especially high predictive value of troponin in
determining the need for revascularization which outweighed the importance of ECG findings on presentation in
making clinical decision regarding catheterization.
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Background
Coronary heart disease (CHD) remains the leading cause
of death in Palestine accounted for 30.6% of total deaths
recorded in 2016 [1]. Cardiac catheterization is per-
formed for diagnostic reasons of CHD, and for revascu-
larization which is achieved by PCI. It can also be
achieved by Coronary Artery Bypass Graft (CABG) when
catheterization is not applicable [2, 3]. The decision to
undertake the catheterization should be based on the
risks and benefits. It might be used as an emergency
procedure to treat a heart attack, open up blocked arter-
ies and prevent further heart damage.
The risk stratification in acute coronary syndrome
(ACS) is usually based on the clinical data obtained dur-
ing hospitalization [4]. Classical considerations for risk
stratification are History, ECG, Age, Risk factors (smok-
ing, hyperlipidemia, obesity) and Troponin [5]. Cardiac-
specific monoclonal antibodies to cardiac troponin I
(TnI) and troponin T (TnT) [6], along with the patient’s
history, physical examination and electrocardiography
are collectively used to predict the need for the most ap-
propriate management plan in ACS.
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Early diagnosis and intervention can be crucial in the
management of patients with ACS. There are several
tools that can lead to the right diagnosis. The presence
of typical chest pain is considered one of them. How-
ever, its absence cannot rule out ACS as in patients with
diabetes, hypertension or elderly patients. ECG is an-
other important tool that is helpful in making the diag-
nosis of ACS, but it lacks sensitivity since 30–50% of
patients may not have any diagnostic changes in their
ECG very early during their presentation [7].
This retrospective cohort study examines risk factors
(age, gender, past medical history including diabetes and
hypertension, history of previous catheterization) to
identify factors which might be correlated with the ne-
cessity of revascularization (PCI/CABG).
Methods
Study design and setting
A retrospective cohort study was conducted at the Heart
Center in Specialized Arab Hospital in Nablus- Palestine.
The study was conducted on data collected from records
of 1550 patients who underwent cardiac catheterization
in 2017. In this study, the significance level was set at a
p-value = < 0.05, and a confidence interval at 95%.
Inclusion and exclusion criteria
The candidates of this study were patients who under-
went cardiac catheterization at Al-Arabi Hospital be-
tween January 2017 and December 2017. Patients who
underwent valve replacement procedures were excluded
from the study.
Data collection tools
Selected sociodemographic and clinical characteristics were
extracted from files of all patients who underwent cardiac
catheterization in 2017at Al-Arabi Heart Center. Data ex-
tracted included specific risk factors (age, gender, past med-
ical history including diabetes and hypertension, history of
previous catheterization). Clinical Laboratory results for the
included subjects were then recorded. Clinical tests in-
cluded cardiac biomarkers (troponin and CK-MB). Further-
more, ECG findings obtained on presentation for each
patient were categorized into: Normal or non-significant
ECG findings, ST segment elevation, ST segment depres-
sion, T wave inversion, and other ECG findings.
Post catheterization outcomes were also documented
and classified as: Normal coronaries for medical treatment,
PCI including stenting or balloon, referral for CABG, this
classification was the final outcome used for analysis.
Statistical analysis
Data was entered, cleaned and managed using Microsoft
Excel. Stata version 14 was used for data analysis. Categor-
ical data was reported as frequencies, continuous data was
reported as means. Bivariate analysis for the main out-
come was conducted using Chi-square test or student t
test when appropriate. Variables with significant p value
were later analyzed in multivariate logistic regression
model. Risk Ratio (RR) and confidence intervals are re-
ported. Significant level is determined at p value ≤0.05.
Results
A total of 1550 patients who underwent cardiac
catheterization at AL-Arabi Heart Center in 2017 were
included in this study. Sociodemographic and pre-
catheterization clinical characteristics of patients were
extracted including age, gender, and existence of chronic
medical diseases such as: diabetes mellitus and hyperten-
sion, history of previous catheterization, ECG findings at
presentation, and other related laboratory values such as:
troponin, CK-MB.
Sociodemographic and clinical characteristics
The mean age of the sample was 57.8, 73.6% were males,
and 79.8% had one ECG change at least. 28,9 and 26.8%
tested positive for Troponin and CK-MB respectively.
Table 1 illustrates sociodemographic and clinical charac-
teristics of the sample.
Predictors of revascularization
Table 2 compares between patients who underwent inter-
ventional and non-interventional cardiac catheterization
in terms of sociodemographic and clinical characteristics.
Age, sex were significantly different between patients who
needed only medical treatment and those who needed re-
vascularization. On the other hand, clinical characteristics
such as ECG on presentation, previous catheterization
and having either diabetes mellitus or hypertension were
significantly different between patient who needed only
medical treatment and those who needed revasculariza-
tion. Among biomarkers, Troponin was significantly cor-
related with revascularization.
After Multivariate logistic regression, Troponin, age, gen-
der, previous catheterization and DM showed significant
difference between patients who underwent an interven-
tional cardiac catheterization and patients with no inter-
vention after heart catheterization (p- value ≤0.05). CK-MB
and Hypertension did not show significant difference. ECG
finding at presentation was significant for ST-elevation and
T wave inversion, but not in case of ST-depression and
other ECG findings. The statistical significance of each
variable for interventional cardiac catheterization, the risk
ratio, p-value and confidence interval of each variable are
listed in Table 3.
Discussion
The management of ACS can be achieved either by med-
ical or invasive methods. Treatment guidelines always start
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with lifestyle changes that focus on diets, smoking cessa-
tion and weight control. Then comes the medical treat-
ment which focuses on treating the underlying conditions
that accelerates atherosclerosis as hypertension, dyslipid-
emia and diabetes. Medical treatment also consists of pre-
ventive treatments [8]. The treatment options also include
revascularization by PCI or coronary artery bypass graft
that are usually used in high-risk patients with acute cor-
onary syndromes as an invasive strategy that provides the
best outcome with a significant reduction in death and MI
compared with an initial conservative strategy.
The most appropriate treatment depends on the pa-
tients’ clinical characteristics and their status in risk
stratifications. However, sometimes choosing the most
appropriate treatment can be unclear due to multiple
factors that may affect treatment plan. The time between
the onset of symptoms and the presentation to the med-
ical the center, the presence of PCI capabilities in the fa-
cility, and the risks/benefits of using thrombolytics if
needed, and other are important factors to consider
upon taking medical decision [9]. Understanding such
factors may facilitate physicians to choose which patients
will benefit from revascularization and when.
Despite the high prevalence of CHD in Palestine, very
limited research has investigated sociodemographic fac-
tors that may facilitate decision making in revasculariza-
tion. This study is the first in Palestine to characterize
the sociodemographic and clinical characteristic of 1550
patients who underwent cardiac catheterization.
The mean age in this study (57.8 years) is similar to find-
ings of neighboring countries [10], and the same is applied
Table 1 Sociodemographic and pre - catheterization clinical
predictive characteristics (N = 1550)
Patients’ Characteristics N (%)
Mean Age (SD) 57.77 (11.68)
Male 1140 (73.55)
ECG (%)1
Normal 294 (19.2)
ST elevation 436 (30.1)
ST depression 193 (12.6)
T wave inversion 279 (18.2)
Others 292 (19.0)
Missing 14 (0.9)
Previous catheterization (%)
N = 1550
604 (39.0)
Diabetes mellitus (%) 627 (40.5)
Hypertension (%) 844 (54.5)
Outcome detailed (%)
Normal/medical treatment 609 (39.3)
PCI 836 (53.9)
CABG 104 (6.7)
Missing 1 (0.1)
Troponin Positive2 353 (28.9)
CK-MB Positive 415 (26.8)
1N = 1536
2 N = 1222
Table 2 Relationship between pre- catheterization predictive characteristics sociodemographic or clinical, and cardiac intervention
(percutaneous coronary intervention/ coronary artery bypass graft)
Intervention
(N = 940)
No intervention
(N = 610)
P-value
Mean Age in years (SD) 59.87 (10.7) 54.53 (12.3) < 0.001
Gender < 0.001
Male — N (%) 739 (64.8) 401 (35.2)
Female — N (%) 209 (51.0) 201 (49.0)
ECG (%) < 0.001
Normal — N (%) 142 (47.8) 155 (52.2)
St-elevation — N (%) 320 (68.7) 147 (31.3)
ST-depression — N (%) 126 (64.6) 69 (35.4)
T wave inversion — N (%) 175 (62.1) 107 (37.9)
Others — N (%) 170 (57.6) 125 (42.4)
Previous catheterization — N (%) 446 (73.8) 158 (26.2) < 0.001
Diabetes mellitus — N (%) 420 (67.0) 208 (33.0) < 0.001
Hypertension — N (%) 537 (63.6) 307 (36.4) 0.009
Troponin positive — N (%) 295 (83.6) 58 (16.4) < 0.001
CK-MB — N (%) 253 (78.3) 70 (21.7) < 0.001
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for gender ratio. Furthermore, Demographic data for pa-
tients undergoing only diagnostic procedures (no inter-
vention) and those undergoing revascularization were
compared. 66.0% of those undergoing diagnostic proced-
ure were males, whereas over three quarters of those who
underwent revascularization were males, while in a study
conducted in the US in 2010 the percentage of male pa-
tients in both diagnostic and interventional groups was a
little bit lower (56, 67%, respectively) [11].
Other findings contradict other published research.
For example, a substantial proportion of patients who
underwent an interventional cardiac catheterization had
diabetes mellitus and/or hypertension with a percentage
of 67.0, 64.0% respectively. These proportions were dif-
ferent in the of Dehmer GJ et al. in the USA which
showed percentages of 36.0%,82.0%, respectively [11].
Moreover, in this current study, it was concluded that
ECG at presentation had a significant predictive value
for undergoing a cardiac catheterization. Similarly, a
study conducted by the Rochester Epidemiology Project
in 2004 found that among patients discharged from the
hospital with a diagnosis of chest pain of undetermined
origin, those with an initial abnormal ECG were at
higher risk for a subsequent adverse cardiac event [12].
Although ST segment deviation, mainly elevation, and T
wave inversion were significant predictors in this study,
normal ECG at presentation did not exclude the need
for cardiac catheterization since a percentage of 19.0% of
patients who needed a cardiac catheterization initially
had a normal ECG at presentation as they had other
clinical or lab findings at the time of presentation that
required cardiac catheterization. Such findings need fur-
ther research and indeed broader clinical criteria for
diagnosis of CHD.
A significant relation between (elevation or depres-
sion) and the subsequent need for an interventional car-
diac catheterization was also deduced from our results,
where 69.0% of patients with ST elevation and 65.0% of
patients with ST depression underwent an revasculariza-
tion thereafter. This is consistent with a study conducted
in Netherlands which suggested that in a patient with
acute chest pain the ECG, using the ST-segment devi-
ation direction, is of value to help accelerate decision-
making by identifying patients most likely to profit from
a rapid revascularization [13].
Creatine kinase (CK) and its MB isoenzyme (CK-MB)
were the most commonly used serologic tests for the
diagnosis of myocardial infarction prior to the wide-
spread adoption of troponin which is now the biomarker
of choice for the detection of cardiac injury since it is
highly sensitive and specific for cardiac injury [14]. This
is consistent with the results of this study which demon-
strated that 52.8% of patients who underwent revascular-
ization were CK-MB negative.
An increased troponin level regardless of CK-MB level
identifies patients at higher risk for ACS than those with
uniformly normal cardiac biomarker levels [15]. In this
study, there was a significant positive predictive value
for troponin regarding the need for revascularization
since 83.6%of troponin positive patients required a re-
vascularization afterward. However, a troponin negative
value per se should not eliminate the consideration of a
cardiac catheterization decision since 50.2% of patients
who have undergone cardiac catheterization and needed
an intervention were troponin negative at presentation.
These results are congruous with the fact that serum
cardiac markers obtained after 6 to 8 h of symptom dur-
ation are highly effective in diagnosing k and can be
used more appropriately to make final clinical decisions
than those obtained within 6 h of symptom onset [16].
These results should be taken into consideration in the
evaluation of patients presenting with chest pain. It is
worth mentioning that backward stepwise regression
was carried out, and it did not produce different results
from the multivariate logistic regression presented.
Clinical predictive significance of troponin and the
clinical picture of the patient (signs and symptoms) for
cardiac catheterization outweighed other predictors, in-
cluding ECG findings, excluding ST-elevation and T
wave inversion. In an American study conducted in
2001 by karras DJet al, it was stated however that “At no
time should results of serum marker tests outweigh ECG
findings or clinical assessment of the patient’s risk and
stability” which may disagrees with the results of this
study regarding the predictive strength of ECG, which
showed that 47.8% of patients who subsequently needed
revascularization initially had a normal ECG at presenta-
tion. Further research and validation should be conducted,
Table 3 Multivariate logistic regression of percutaneous
coronary intervention and coronary artery bypass graft with
sociodemographic and pre-catheterization clinical predictors
RRa P-Value 95% CI
Positive Troponin 4.5 < 0.001 3.00 6.88
Positive CK-MB 1.3 0.197 0.87 1.97
Age 1.0 < 0.001 1.02 1.05
Female Gender 0.4 < 0.001 0.29 0.54
Previous Cath. 2.0 < 0.001 1.51 2.65
DM 1.4 0.033 1.02 1.81
HTN 1.3 0.095 0.96 1.68
ECG presentation
St-elevation 1.5 0.046 1.01 2.15
ST-depression 1.6 0.066 0.97 2.50
T wave inversion 1.6 0.038 1.02 2.39
Others 0.9 0.681 0.61 1.39
aAdjusted risk ratio
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but these results stress on the fact that the clinical presen-
tation of the patient remains the mainstay of clinical deci-
sion whether to undergo a cardiac catheterization or not.
Conclusion
This study assessed interventional cardiac catheterization
predictors in addition to characteristics and outcomes of
patients who have undergone cardiac catheterization. The
results of this investigation showed that the clinical predict-
ive significance of troponin and the clinical picture of the
patient (signs and symptoms) for cardiac catheterization
outweighed other predictors including ECG findings on
presentation. Physicians should be alert enough to the clin-
ical history and presenting symptoms rather than only de-
pending on laboratory values and ECG interpretation
particularly when they are equivocal.
Furthermore, the results of this study can be used by
physicians and researchers to further establish evidence
based guidelines that can be used in the clinical decision of
carrying out cardiac catheterization procedures in order to
decrease related cardiac morbidity and mortality. Never-
theless, future studies concerning the approach to patients
presenting with cardiac symptoms are needed.
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